233 related articles for article (PubMed ID: 23429673)
21. Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.
Sugimoto M; Uotani T; Ichikawa H; Andoh A; Furuta T
Digestion; 2016; 93(1):24-31. PubMed ID: 26789391
[TBL] [Abstract][Full Text] [Related]
22. Dysfunction of oesophageal motility in Helicobacter pylori-infected patients with reflux oesophagitis.
Wu JC; Lai AC; Wong SK; Chan FK; Leung WK; Sung JJ
Aliment Pharmacol Ther; 2001 Dec; 15(12):1913-9. PubMed ID: 11736722
[TBL] [Abstract][Full Text] [Related]
23. Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy.
Sasaki A; Haruma K; Manabe N; Tanaka S; Yoshihara M; Chayama K
Aliment Pharmacol Ther; 2003 Jun; 17(12):1529-34. PubMed ID: 12823156
[TBL] [Abstract][Full Text] [Related]
24. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
25. Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.
Jonaitis L; Kiudelis G; Kupcinskas L
Medicina (Kaunas); 2008; 44(3):211-5. PubMed ID: 18413988
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
Vasapolli R; Malfertheiner P; Kandulski A
Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease.
Xie T; Cui X; Zheng H; Chen D; He L; Jiang B
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1195-205. PubMed ID: 23839160
[TBL] [Abstract][Full Text] [Related]
28. Key Issues Associated with Helicobacter pylori Eradication.
Kawai T; Moriyasu F; Tsuchida A
Digestion; 2016; 93(1):19-23. PubMed ID: 26788997
[TBL] [Abstract][Full Text] [Related]
29. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection.
Vakil N; Hahn B; McSorley D
Aliment Pharmacol Ther; 2000 Jan; 14(1):45-51. PubMed ID: 10632644
[TBL] [Abstract][Full Text] [Related]
30. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
[TBL] [Abstract][Full Text] [Related]
31. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis.
Yang YJ; Sheu BS; Chang WL; Cheng HC; Yang HB
J Clin Gastroenterol; 2009 Sep; 43(8):705-10. PubMed ID: 19398924
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease.
Zentilin P; Iiritano E; Vignale C; Bilardi C; Mele MR; Spaggiari P; Gambaro C; Dulbecco P; Tessieri L; Reglioni S; Mansi C; Mastracci L; Vigneri S; Fiocca R; Savarino V
Aliment Pharmacol Ther; 2003 Apr; 17(8):1057-64. PubMed ID: 12694088
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
[TBL] [Abstract][Full Text] [Related]
34. [Prevalence of Helicobacter pylori infection among children and youth with acid gastroesophageal reflux].
Brazowski J; Nowak A; Szaflarska-Popławska A
Przegl Lek; 2006; 63(3):128-30. PubMed ID: 16967700
[TBL] [Abstract][Full Text] [Related]
35. [Eradication of Helicobacter pylori possibly followed by gastroesophageal reflux disease].
Loffeld RJ
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2505-7. PubMed ID: 10627750
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
[TBL] [Abstract][Full Text] [Related]
37. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.
Raghunath AS; Hungin AP; Wooff D; Childs S
Aliment Pharmacol Ther; 2004 Oct; 20(7):733-44. PubMed ID: 15379833
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M
Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809
[TBL] [Abstract][Full Text] [Related]
39. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Jonaitis L; Kupčinskas J; Kiudelis G; Kupčinskas L
Medicina (Kaunas); 2010; 46(7):454-9. PubMed ID: 20966617
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
